1. The Utility of PET/Computed Tomography for Radiation Oncology Planning, Surveillance, and Prognosis Prediction of Gastrointestinal Tumors
- Author
-
Charles B. Simone, Jason K. Molitoris, O.M. Siddiqui, Ankur M. Sharma, Antony Koroulakis, Michael D. Chuong, Adeel Kaiser, and Stephanie R. Rice
- Subjects
medicine.medical_specialty ,Prognosis prediction ,Gastrointestinal tumors ,Computed tomography ,Patient Care Planning ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Positron Emission Tomography Computed Tomography ,Radiation oncology ,Humans ,Medicine ,Radiology, Nuclear Medicine and imaging ,Recurrence prediction ,Radiation treatment planning ,Gastrointestinal Neoplasms ,Neoplasm Staging ,Postoperative Care ,PET-CT ,Radiation ,medicine.diagnostic_test ,business.industry ,General Medicine ,Prognosis ,Neoadjuvant Therapy ,030220 oncology & carcinogenesis ,Ct scanners ,Radiology ,Neoplasm Recurrence, Local ,business - Abstract
At present, the strongest evidence for the use of PET/computed tomography (CT) in gastrointestinal (GI) malignancies is to rule out distant metastatic disease at diagnosis, radiation treatment planning for anal malignancies, and disease recurrence monitoring in colorectal and anal malignancies. Use of PET/CT for GI malignancies continues to evolve over time, with new studies evaluating prognostic abilities of PET/CT and with increasing sensitivity and spatial resolution of more modern PET/CT scanners. The authors encourage future applications and prospective evaluation of the use of PET/CT in the staging, prognostication, and recurrence prediction for GI malignancies.
- Published
- 2020
- Full Text
- View/download PDF